ABOUT US
Why the Name
“HeLaSync”?
The story behind our name — and the responsibility it asks us to carry.
The name HeLaSync honors the life and legacy of Henrietta Lacks, a Black woman whose cancer cells were taken without her consent in 1951 at Johns Hopkins Hospital. Her cells—known as HeLa cells—became the first immortal human cell line, revolutionizing science and leading to breakthroughs in the polio vaccine, cancer treatment, HIV/AIDS research, genetics, and even space exploration.
Yet, her family was left in the dark for decades, receiving neither recognition nor compensation. Her story is a powerful symbol of both the immense contributions of Black bodies to science and the deep ethical injustices that have historically excluded those same bodies from equitable participation.
At HeLaSync, we carry her legacy forward—not only to acknowledge the past but to actively reshape the future of healthcare research to be more inclusive, ethical, and just.
WHAT HER CELLS MADE POSSIBLE
Breakthroughs built on HeLa cells.
- Polio vaccine
- Cancer treatment
- HIV/AIDS research
- Genetics
- Space exploration
OUR MISSION
Making Research Opportunities More Accessible to Every Community.
Better research starts with broader representation. We believe opportunities to participate should be easier to identify, understand, and discuss.
By embedding research awareness into routine care, HeLaSync aims to reduce barriers to discovery and improve coordination between care teams and research teams.
Discover Our MissionLET’S BUILD THE CONNECTION
Bring Clinical Research
Into Your Workflow.
Partner with HeLaSync to explore how point-of-care clinical trial identification and provider education can fit into your existing clinical environment.
Partner With Us